Surface Oncology, Inc. (SURF) Social Stream



Surface Oncology, Inc. (SURF): $7.23

-0.32 (-4.24%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Surface Oncology Inc (SURF) Price Targets From Analysts

Use the tables below to see what analysts covering Surface Oncology Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
5 $18 $14 $15.6 $7.4 110.81%

The Trend in the Analyst Price Target


SURF's average price target has moved up $5.27 over the prior 16 months.

Over the past 16 months, SURF's average upside potential has been 87.56%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-19 5 18 14 15.60 7.10 119.72%
2021-09-18 5 18 14 15.60 7.10 119.72%
2021-09-11 5 18 14 15.60 6.11 155.32%
2021-08-19 5 18 14 15.60 5.38 189.96%
2021-08-14 5 18 14 15.60 5.64 176.6%
2021-08-07 5 18 14 15.60 5.70 173.68%
2021-07-07 5 18 14 16.40 6.89 138.03%
2021-07-03 5 18 14 16.40 7.19 128.09%
2021-06-04 5 18 14 16.40 8.17 100.73%
2021-05-22 5 18 14 16.40 8.72 88.07%
2021-05-15 4 18 14 16.25 7.87 106.48%
2021-05-08 4 18 14 16.25 7.92 105.18%
2021-04-25 4 18 14 16.25 7.01 131.81%
2021-04-17 4 18 14 16.25 6.79 139.32%
2021-04-10 5 18 12 15.40 7.95 93.71%
2021-04-03 5 18 12 15.40 8.09 90.36%
2021-03-20 5 18 12 15.40 9.50 62.11%
2021-03-13 5 18 12 15.40 9.23 66.85%
2021-03-06 5 18 12 15.40 7.50 105.33%
2021-02-27 5 18 12 15.40 8.48 81.6%
2021-02-20 5 18 12 15.40 9.50 62.11%
2021-02-13 5 18 12 15.40 11.24 37.01%
2021-02-06 5 18 12 15.40 11.17 37.87%
2021-01-30 5 18 12 15.40 11.06 39.24%
2021-01-23 5 18 12 15.40 13.31 15.7%
2021-01-16 5 18 12 15.40 12.30 25.2%
2021-01-09 5 18 12 15.40 10.70 43.93%
2021-01-02 5 18 12 15.40 9.24 66.67%
2020-12-26 5 18 12 15.40 9.63 59.92%
2020-12-19 5 18 12 14.80 9.04 63.72%
2020-12-10 5 15 11 13.00 9.68 34.3%
2020-12-07 5 15 11 13.00 8.32 56.25%
2020-11-28 5 15 11 13.00 7.86 65.39%
2020-11-13 5 15 11 13.00 8.61 50.99%
2020-11-12 5 15 9 12.40 9.28 33.62%
2020-09-03 5 12 9 10.80 NA NA%
2020-08-26 4 12 9 10.75 NA NA%
2020-05-12 3 12 9 10.33 NA NA%

SURF Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.25 3 3 0 0 0 6

The Trend in the Broker Recommendations


SURF's average broker recommendation rating improved by 0.1 over the prior 123 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • SURF has a higher upside potential (average analyst target price relative to current price) than 83.52% of all US stocks.
  • Surface Oncology Inc's average analyst price target is greater than 30.05% of all US stocks.
  • Surface Oncology Inc's variance in analysts' estimates is less than 69.79% of Pharmaceutical Products stocks.
  • Surface Oncology Inc's number of analysts covering the stock is greater than 69.02% of stocks in the small market cap category.

In the Pharmaceutical Products industry, ACRS, SELB and RIOT are the three stocks most similar to Surface Oncology Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding SURF using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.904 seconds.